PAK4 as a potential marker for poor response to immunotherapy in melanoma patients
Literature
Read More
NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022
Press Release
Read More
NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press Release
Read More
NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
Press Release
Read More